Everything Draft and the Ultimate Pick Party! See Kenny Chesney in Las Vegas Y100’s 2025 Barstool Brackets winner is… Shotgun & Charli Birthday Club Submit your community events here! Wake Up With Shotgun & Charli Farmer of the Month News From The Pack Blog Grab Your Y100 Merch! Take Our Listener Survey St. Jude Jam 20

  • 490articles · 30d
  • 1+ day agolatest article
  • Aug 15, 2026earliest in window
  • 20%with images
  • 301avg words
articles per day
Categories
  • News 158
  • Economy, Business & Finance 126
  • Sports & Fitness 112
  • Politics 111
  • Sports 111
  • Sport 101
  • Finance & Business 95
  • Politics2 80

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

wncy.com
wncy.com > 09/10/2026 > us-fda-pauses-new-enrollment-in-biohavens-epilepsy-drug-trials

US FDA pauses new enrollment in Biohaven’s epilepsy drug trials

3+ day, 17+ hour ago   (293+ words) Sept 10 (Reuters) – Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials of its experimental epilepsy drug ​after rodent findings, sending its shares down more than ‌15% in early trading. • The U....

wncy.com
wncy.com > 09/09/2026 > tencent-backed-enflame-to-debut-in-shanghai-on-friday-in-912-million-ipo

Tencent-backed Enflame to debut in Shanghai on Friday in $912 million IPO

4+ day, 18+ hour ago   (237+ words) BEIJING, Sept 9 (Reuters) – Tencent-backed AI chipmaker Shanghai Enflame Technology will make its Shanghai stock market debut on September 11, an ​exchange filing showed on Wednesday. Enflame, one ‌of China’s leading AI chip startups known locally as the “four little GPU dragons…...

wncy.com
wncy.com > 09/09/2026 > khrzhanovsky-brings-long-awaited-dau-to-venice-following-ukraine-row

Khrzhanovsky brings long-awaited ‘DAU’ to Venice following Ukraine row

4+ day, 18+ hour ago   (560+ words) VENICE, Sept 9 (Reuters) – A film shot when war between Russia and Ukraine seemed unthinkable finally hit Venice on Wednesday, with director Ilya Khrzhanovsky unveiling “DAU”, a 20-year project that has generated both fascination and controversy. Ukraine’s government has objected to…...

wncy.com
wncy.com > 09/09/2026 > republican-lawmakers-criticize-ford-business-ties-to-china

Republican lawmakers criticize Ford business ties to China

4+ day, 18+ hour ago   (59+ words) Y100 WNCY Republican lawmakers criticize Ford business ties to China WASHINGTON, Sept 9 (Reuters) – Republicans in Congress on Wednesday ​joined criticism of Ford Motor over its business ties to Chinese firms after ​Transportation ⁠Secretary Sean Duffy ⁠sharply criticized the No. 2 U.S....

wncy.com
wncy.com > 09/08/2026 > dyne-sarepta-shares-tumble-as-novartis-setback-weighs-on-muscle-disease-drug-developers

Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers

5+ day, 11+ hour ago   (317+ words) Sept 8 (Reuters) – Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis’ treatment for a muscle-wasting disorder failed in a trial, fueling investor concerns ​about the prospects of similar therapies for the tough-to-treat ‌rare disease. Dyne’s stock led declines…...

wncy.com
wncy.com > 09/08/2026 > bristol-myers-blood-cancer-cell-therapy-meets-main-goal-in-mid-stage-trial

Bristol Myers’ blood cancer cell therapy succeeds in mid-stage trial

5+ day, 19+ hour ago   (257+ words) Sept 8 (Reuters) – Bristol Myers Squibb said on Tuesday its experimental cell therapy showed a high overall response rate in a mid-stage trial, ​in patients with a hard-to-treat form of ‌blood cancer. The study evaluated the therapy, called arlocabtagene autoleucel, or…...

wncy.com
wncy.com > 09/07/2026 > novo-scraps-two-more-heart-drug-trials-further-dimming-growth-beyond-obesity

Novo scraps two more heart drug trials, further dimming growth beyond obesity

6+ day, 19+ hour ago   (191+ words) Sept 7 (Reuters) – Novo Nordisk said on Monday it had halted two additional trials of its ​experimental cardiovascular drug ziltivekimab, further ‌denting the Danish drugmaker’s efforts to diversify beyond its blockbuster obesity and diabetes franchise. In July, Novo said ziltivekimab failed…...

wncy.com
wncy.com > 09/07/2026 > european-shares-dip-as-rise-in-oil-prices-weighs-novartis-slips

European shares dip as higher oil prices weigh; Novartis slips

1+ week, 3+ hour ago   (452+ words) Sept 7 (Reuters) – European shares edged lower on Monday as oil prices climbed after a fresh exchange of strikes between the United States and Iran, fuelling inflation concerns and bolstering expectations that the European Central Bank may need to keep ​raising…...

wncy.com
wncy.com > 09/06/2026 > uk-recruiters-see-first-rise-in-permanent-role-hiring-since-2022

UK recruiters see first rise in permanent role hiring since 2022

1+ week, 11+ hour ago   (134+ words) LONDON, Sept 7 (Reuters) – Britain’s jobs market showed signs of recovery in August ​as permanent staff ‌placements rose for the first time since September 2022, according to a survey published on ‌Monday. The ​monthly gauge ⁠of permanent job ⁠placements from the Recruitment…...

wncy.com
wncy.com > 09/06/2026 > oil-extends-gains-after-us-and-iran-strike-ships

Oil extends gains after US and Iran strike ships

1+ week, 11+ hour ago   (420+ words) By Florence Tan and Sam Li SINGAPORE, Sept 7 (Reuters) – Oil prices extended gains on Monday as tit-for-tat strikes between the U.S. and Iran on vessels sailing in the Strait of Hormuz and other areas heightened concerns of a prolonged ​supply…...